首页 > 最新文献

Birth Defects Research最新文献

英文 中文
Association Between Fetal Congenital Heart Disease and Assisted Reproductive Technologies in the First Trimester of Pregnancy: A Retrospective Study. 妊娠前三个月胎儿先天性心脏病与辅助生殖技术的相关性:一项回顾性研究
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70030
Ilaria Giuditta Ramezzana, Marco Reschini, Simona Boito, Lucia Mauri, Anastasia Giri, Edgardo Somigliana, Nicola Persico

Objective: To determine whether there is a higher rate of major fetal congenital heart diseases (CHDs) at first-trimester scan in pregnancies conceived by assisted reproductive technology (ART).

Methods: A retrospective study was conducted from 2014 to 2022. It included 20,009 singleton pregnancies undergoing ultrasound between 11 and 15 weeks for first-trimester aneuploidy screening or referral for suspected fetal abnormality. Fetal heart assessment was performed through sequential analysis. In cases of CHDs, extracardiac malformations, or other risk factors for major aneuploidies, fetal karyotype evaluation was conducted. CHDs were categorized as major or minor.

Results: A CHD was diagnosed in 133 (0.7%) of 18,532 natural pregnancies and 14 (0.9%) of 1477 ART pregnancies. The prevalence of major CHDs in natural pregnancies was 0.5%, with no significant difference compared to ART pregnancies (0.7%; p = 0.47). Overall, 48 CHD cases (43.2%) were associated with extracardiac abnormalities, with no differences between natural and ART pregnancies (p = 0.38). The frequency of abnormal karyotype and isolated CHDs (normal karyotype and no extracardiac abnormalities) also did not differ.

Conclusion: The rate of major CHDs detectable at the end of the first trimester does not differ between ART and natural pregnancies.

目的:探讨辅助生殖技术(ART)妊娠早期扫描中主要胎儿先天性心脏病(CHDs)的检出率是否较高。方法:2014 ~ 2022年进行回顾性研究。该研究包括在11至15周期间接受超声检查的20,000名单胎孕妇,用于妊娠早期非整倍体筛查或疑似胎儿异常的转诊。通过序贯分析对胎儿心脏进行评估。在有冠心病、心外畸形或其他主要非整倍体危险因素的情况下,进行胎儿核型评估。冠心病分为严重和轻微。结果:18532例自然妊娠中有133例(0.7%)诊断为冠心病,1477例ART妊娠中有14例(0.9%)诊断为冠心病。自然妊娠中主要冠心病的患病率为0.5%,与ART妊娠相比无显著差异(0.7%;p = 0.47)。总体而言,48例冠心病(43.2%)与心外异常相关,自然妊娠与ART妊娠之间无差异(p = 0.38)。异常核型和孤立冠心病(核型正常,无心外异常)的发生频率也无差异。结论:ART与自然妊娠在妊娠早期晚期主要冠心病检出率无显著差异。
{"title":"Association Between Fetal Congenital Heart Disease and Assisted Reproductive Technologies in the First Trimester of Pregnancy: A Retrospective Study.","authors":"Ilaria Giuditta Ramezzana, Marco Reschini, Simona Boito, Lucia Mauri, Anastasia Giri, Edgardo Somigliana, Nicola Persico","doi":"10.1002/bdr2.70030","DOIUrl":"https://doi.org/10.1002/bdr2.70030","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether there is a higher rate of major fetal congenital heart diseases (CHDs) at first-trimester scan in pregnancies conceived by assisted reproductive technology (ART).</p><p><strong>Methods: </strong>A retrospective study was conducted from 2014 to 2022. It included 20,009 singleton pregnancies undergoing ultrasound between 11 and 15 weeks for first-trimester aneuploidy screening or referral for suspected fetal abnormality. Fetal heart assessment was performed through sequential analysis. In cases of CHDs, extracardiac malformations, or other risk factors for major aneuploidies, fetal karyotype evaluation was conducted. CHDs were categorized as major or minor.</p><p><strong>Results: </strong>A CHD was diagnosed in 133 (0.7%) of 18,532 natural pregnancies and 14 (0.9%) of 1477 ART pregnancies. The prevalence of major CHDs in natural pregnancies was 0.5%, with no significant difference compared to ART pregnancies (0.7%; p = 0.47). Overall, 48 CHD cases (43.2%) were associated with extracardiac abnormalities, with no differences between natural and ART pregnancies (p = 0.38). The frequency of abnormal karyotype and isolated CHDs (normal karyotype and no extracardiac abnormalities) also did not differ.</p><p><strong>Conclusion: </strong>The rate of major CHDs detectable at the end of the first trimester does not differ between ART and natural pregnancies.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70030"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Influence of Maternal Melatonin on Embryo Implantation: A Crucial Factor in Reproductive Outcomes. 母体褪黑素对胚胎着床的影响:生殖结局的关键因素。
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70021
Tannaz Novinbahador, Sina Abroon, Kimia Motlagh, Mohammad Nouri

Background: This review aimed to investigate the effect of melatonin on the maternal side of the implantation process. Additionally, reproductive factors involved in changing melatonin levels and vice versa, will also be discussed.

Methods: The authors collected the relevant articles published until 2024 and these are carefully selected from PubMed, Embase, Google scholar databases on the basis of related keywords.

Results: Melatonin could improve the endometrial receptivity and has been shown to act directly on several reproductive events, including folliculogenesis, oocyte maturation, and corpus luteum (CL) formation. Melatonin administration reduces oxidative stress and directly acts on its membrane receptors and melatonin thyroid hormone receptors (MT1 and MT2). Also, melatonin displays effects on the earliest phases of pregnancy and during the whole gestational period. Many studies have reported the anticancer effect of melatonin against a myriad of women cancer types. A new report by WHO revealed that around 17.5% of the adult population experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need.

Conclusions: This study shows that melatonin is present in the ovary and the placenta and has positive effects in the maternal reproductive system.

背景:本综述旨在探讨褪黑素对母体植入过程的影响。此外,生殖因素参与改变褪黑激素水平,反之亦然,也将讨论。方法:作者根据相关关键词从PubMed、Embase、谷歌学者数据库中精选出截止2024年发表的相关文章。结果:褪黑素可以改善子宫内膜容受性,并被证明直接作用于几个生殖事件,包括卵泡发生、卵母细胞成熟和黄体(CL)形成。褪黑素可以减少氧化应激,并直接作用于其膜受体和褪黑素甲状腺激素受体(MT1和MT2)。此外,褪黑素对妊娠早期和整个妊娠期都有影响。许多研究报告了褪黑素对多种女性癌症类型的抗癌作用。世卫组织的一份新报告显示,约17.5%的成年人口患有不孕症,这表明迫切需要为有需要的人增加获得负担得起的高质量生育保健的机会。结论:本研究表明,褪黑素存在于卵巢和胎盘中,对母体生殖系统有积极作用。
{"title":"The Influence of Maternal Melatonin on Embryo Implantation: A Crucial Factor in Reproductive Outcomes.","authors":"Tannaz Novinbahador, Sina Abroon, Kimia Motlagh, Mohammad Nouri","doi":"10.1002/bdr2.70021","DOIUrl":"https://doi.org/10.1002/bdr2.70021","url":null,"abstract":"<p><strong>Background: </strong>This review aimed to investigate the effect of melatonin on the maternal side of the implantation process. Additionally, reproductive factors involved in changing melatonin levels and vice versa, will also be discussed.</p><p><strong>Methods: </strong>The authors collected the relevant articles published until 2024 and these are carefully selected from PubMed, Embase, Google scholar databases on the basis of related keywords.</p><p><strong>Results: </strong>Melatonin could improve the endometrial receptivity and has been shown to act directly on several reproductive events, including folliculogenesis, oocyte maturation, and corpus luteum (CL) formation. Melatonin administration reduces oxidative stress and directly acts on its membrane receptors and melatonin thyroid hormone receptors (MT1 and MT2). Also, melatonin displays effects on the earliest phases of pregnancy and during the whole gestational period. Many studies have reported the anticancer effect of melatonin against a myriad of women cancer types. A new report by WHO revealed that around 17.5% of the adult population experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need.</p><p><strong>Conclusions: </strong>This study shows that melatonin is present in the ovary and the placenta and has positive effects in the maternal reproductive system.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70021"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal Trends in Fetal Congenital Heart Disease: Is There a Potential Link With Air Quality? 胎儿先天性心脏病的时间趋势:与空气质量有潜在联系吗?
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70026
Natalie L Ewing, Mary T Donofrio, Gary M Shaw, Jennifer H Klein

Background: Congenital heart disease (CHD) is the most common birth defect. Environmental risk factors, including air pollution, are increasingly identified as contributors to the risk profile of CHD. We sought to investigate the temporal association between frequency and severity of fetal CHD with air quality in the D.C. metropolitan region.

Methods: We queried all fetal diagnoses of CHD at a tertiary care center over a 5-year period, inclusive of a wildfire smoke event. We categorized each case as critical or non-critical CHD and assigned the case to the estimated month of delivery. We used descriptive statistics to show temporal trends in fetal CHD and the relationship with publicly available air quality data.

Results: Of the 685 CHD cases, approximately 60% were considered critical CHD. The highest number of cases occurred in March 2024 (coincident with a periconception period in June 2023 during peak wildfire smoke exposure). An additional peak in CHD cases in February 2023 also coincided with a worse air quality peak during the cardiac embryonic period. However, there was no change in the percentage of critical CHD during these peaks.

Conclusion: Our work highlights the possibility of environmental pollution, specifically wildfire smoke exposure, as a risk factor for fetal CHD.

背景:先天性心脏病(CHD)是最常见的出生缺陷。环境风险因素,包括空气污染,越来越多地被认为是导致冠心病风险概况的因素。我们试图调查胎儿冠心病的频率和严重程度与华盛顿大都会地区空气质量之间的时间关系。方法:我们查询了一家三级保健中心5年来所有的胎儿冠心病诊断,包括一次野火烟雾事件。我们将每个病例分类为重症或非重症冠心病,并将病例分配到预计的分娩月份。我们使用描述性统计来显示胎儿冠心病的时间趋势以及与公开可获得的空气质量数据的关系。结果:在685例冠心病病例中,约60%被认为是危重型冠心病。病例数最多的发生在2024年3月(与2023年6月野火烟雾暴露高峰期间的感知期一致)。2023年2月冠心病病例的另一个高峰也恰逢心脏胚胎期空气质量较差的高峰。然而,在这些高峰期间,临界冠心病的百分比没有变化。结论:我们的工作强调了环境污染的可能性,特别是野火烟雾暴露,是胎儿冠心病的危险因素。
{"title":"Temporal Trends in Fetal Congenital Heart Disease: Is There a Potential Link With Air Quality?","authors":"Natalie L Ewing, Mary T Donofrio, Gary M Shaw, Jennifer H Klein","doi":"10.1002/bdr2.70026","DOIUrl":"https://doi.org/10.1002/bdr2.70026","url":null,"abstract":"<p><strong>Background: </strong>Congenital heart disease (CHD) is the most common birth defect. Environmental risk factors, including air pollution, are increasingly identified as contributors to the risk profile of CHD. We sought to investigate the temporal association between frequency and severity of fetal CHD with air quality in the D.C. metropolitan region.</p><p><strong>Methods: </strong>We queried all fetal diagnoses of CHD at a tertiary care center over a 5-year period, inclusive of a wildfire smoke event. We categorized each case as critical or non-critical CHD and assigned the case to the estimated month of delivery. We used descriptive statistics to show temporal trends in fetal CHD and the relationship with publicly available air quality data.</p><p><strong>Results: </strong>Of the 685 CHD cases, approximately 60% were considered critical CHD. The highest number of cases occurred in March 2024 (coincident with a periconception period in June 2023 during peak wildfire smoke exposure). An additional peak in CHD cases in February 2023 also coincided with a worse air quality peak during the cardiac embryonic period. However, there was no change in the percentage of critical CHD during these peaks.</p><p><strong>Conclusion: </strong>Our work highlights the possibility of environmental pollution, specifically wildfire smoke exposure, as a risk factor for fetal CHD.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70026"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146123422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing of Secondary Palate Fusion in Human Embryos and Fetuses. 人类胚胎和胎儿的次腭融合时机。
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70029
Puck Pauline Mulder, Jess Johanna Peters, Yousif Dawood, Karl Jacobs, Sophie Caroline Visser, Jaco Hagoort, Jermo Hanemaaijer-van der Veer, Robert Hemke, Eva Pajkrt, Roelof-Jan Oostra, Corstiaan Cornelis Breugem, Bernadette Simone de Bakker

Introduction: The human face develops through a complex sequence of growth and fusion events involving multiple pharyngeal arch derivatives. Disruptions in these processes can result in congenital anomalies such as cleft lip and/or palate (CL/P), which occur in approximately 1.6 per 1000 live births in Europe. Patients with CL/P often experience difficulties regarding feeding and speech, and studies suggest an increased risk of psychosocial difficulties. Understanding the morphological development and timing of secondary palate formation is essential for clarifying the pathogenesis of CL/P and identifying critical developmental periods during pregnancy. In this study, we aimed to evaluate the timing and morphological changes of the secondary palate in human embryos between Carnegie Stages 17-23 and fetuses aged 9-11 weeks post-conception (PC).

Methods: Histological sections and micro-CT scans of 26 human specimens, evenly distributed across these developmental stages, were analyzed.

Results: The results showed that palatal shelves first appear at CS18 and continue vertical outgrowth until CS22. At CS22, the shelves start to reorient horizontally and further extend medially. Shelf contact is observed at CS23, marking the onset of fusion, which is completed during or after 9 weeks PC.

Conclusions: These findings refine the timeline of human secondary palate development. Importantly, identifying this critical developmental window suggests that current guidelines for administering medications during early pregnancy should be reevaluated, as drug exposure during this sensitive period may increase the risk of palatal malformations.

人脸的发育是通过一系列复杂的生长和融合事件,涉及多个咽弓衍生物。这些过程的中断可导致先天性异常,如唇裂和/或腭裂(CL/P),在欧洲,每1000例活产婴儿中约有1.6例发生唇裂和/或腭裂。CL/P患者通常在进食和言语方面遇到困难,研究表明心理社会困难的风险增加。了解二次腭的形态发育和形成时间对于明确CL/P的发病机制和确定妊娠期的关键发育时期至关重要。在这项研究中,我们旨在评估人类胚胎在卡内基期17-23和胎龄9-11周(PC)之间的次腭的时间和形态变化。方法:对均匀分布于不同发育阶段的26例人体标本进行组织学切片和显微ct扫描分析。结果:腭架最早出现于CS18,并持续垂直生长至CS22。在CS22,架子开始水平重新定位,并进一步向中间延伸。在CS23观察到架子接触,标志着融合的开始,融合在9周PC期间或之后完成。结论:这些发现完善了人类第二腭发育的时间表。重要的是,确定这一关键的发育窗口期表明,应重新评估当前妊娠早期用药指南,因为在这一敏感时期接触药物可能会增加腭畸形的风险。
{"title":"Timing of Secondary Palate Fusion in Human Embryos and Fetuses.","authors":"Puck Pauline Mulder, Jess Johanna Peters, Yousif Dawood, Karl Jacobs, Sophie Caroline Visser, Jaco Hagoort, Jermo Hanemaaijer-van der Veer, Robert Hemke, Eva Pajkrt, Roelof-Jan Oostra, Corstiaan Cornelis Breugem, Bernadette Simone de Bakker","doi":"10.1002/bdr2.70029","DOIUrl":"https://doi.org/10.1002/bdr2.70029","url":null,"abstract":"<p><strong>Introduction: </strong>The human face develops through a complex sequence of growth and fusion events involving multiple pharyngeal arch derivatives. Disruptions in these processes can result in congenital anomalies such as cleft lip and/or palate (CL/P), which occur in approximately 1.6 per 1000 live births in Europe. Patients with CL/P often experience difficulties regarding feeding and speech, and studies suggest an increased risk of psychosocial difficulties. Understanding the morphological development and timing of secondary palate formation is essential for clarifying the pathogenesis of CL/P and identifying critical developmental periods during pregnancy. In this study, we aimed to evaluate the timing and morphological changes of the secondary palate in human embryos between Carnegie Stages 17-23 and fetuses aged 9-11 weeks post-conception (PC).</p><p><strong>Methods: </strong>Histological sections and micro-CT scans of 26 human specimens, evenly distributed across these developmental stages, were analyzed.</p><p><strong>Results: </strong>The results showed that palatal shelves first appear at CS18 and continue vertical outgrowth until CS22. At CS22, the shelves start to reorient horizontally and further extend medially. Shelf contact is observed at CS23, marking the onset of fusion, which is completed during or after 9 weeks PC.</p><p><strong>Conclusions: </strong>These findings refine the timeline of human secondary palate development. Importantly, identifying this critical developmental window suggests that current guidelines for administering medications during early pregnancy should be reevaluated, as drug exposure during this sensitive period may increase the risk of palatal malformations.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70029"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Some Complementary Medicine Active Components on Rat Embryonic Heart Rate In Vitro. 一些补充药物活性成分对体外大鼠胚胎心率的影响。
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70016
Helen E Ritchie, Andrea Xia, Jaimie W Polson

Introduction: Most complementary and alternative medicines (CAMs) lack clinical safety regarding use in pregnancy, yet they are freely available and do not require a prescription. While all new conventional medicines are assessed for safety during pregnancy, CAMs are exempt. In vitro testing potentially provides a rapid screening method to support risk assessment. Whole rat embryo culture can be used to identify the impact of chemicals on the embryonic heart rate. There is clear evidence that slowing of the embryonic heart rate (bradycardia) can cause spontaneous abortions and fetal malformations. The aim of this study was to examine the effect of four commonly used CAMs on the embryonic heart rate in vitro. A risk assessment was then generated from the results.

Methods: Gestation day 13 rat embryos were exposed to the active ingredient of four herbal medicines: allicin (garlic), epigallocatechin-gallate (green tea), ginsenoside Rg3 (found in ginseng), and berberine (goldenseal). All ingredients caused embryonic bradycardia.

Results and conclusion: The margin of safety was acceptable for EGCG and ginsenoside Rg3 but could not be calculated for allicin due to lack of pharmacokinetic data. The margin of safety for berberine is also likely to be acceptable under most conditions.

大多数补充和替代药物(CAMs)在妊娠期间使用缺乏临床安全性,但它们是免费提供的,不需要处方。虽然所有新的传统药物都要对怀孕期间的安全性进行评估,但cam不受此限制。体外测试有可能提供一种支持风险评估的快速筛选方法。全鼠胚胎培养可用于鉴定化学物质对胚胎心率的影响。有明确的证据表明,胚胎心率减慢(心动过缓)可导致自然流产和胎儿畸形。本研究的目的是研究四种常用的CAMs对体外胚胎心率的影响。然后根据结果生成风险评估。方法:将妊娠第13天的大鼠胚胎暴露于四种有效成分:大蒜素(大蒜)、表没食子儿茶素没食子酸酯(绿茶)、人参皂苷Rg3(人参中发现)和小檗碱(金毛)。所有成分都引起了胚胎性心动过缓。结果与结论:EGCG和人参皂苷Rg3的安全边际可接受,而大蒜素由于缺乏药动学数据而无法计算安全边际。在大多数情况下,小檗碱的安全范围也可能是可以接受的。
{"title":"The Effect of Some Complementary Medicine Active Components on Rat Embryonic Heart Rate In Vitro.","authors":"Helen E Ritchie, Andrea Xia, Jaimie W Polson","doi":"10.1002/bdr2.70016","DOIUrl":"https://doi.org/10.1002/bdr2.70016","url":null,"abstract":"<p><strong>Introduction: </strong>Most complementary and alternative medicines (CAMs) lack clinical safety regarding use in pregnancy, yet they are freely available and do not require a prescription. While all new conventional medicines are assessed for safety during pregnancy, CAMs are exempt. In vitro testing potentially provides a rapid screening method to support risk assessment. Whole rat embryo culture can be used to identify the impact of chemicals on the embryonic heart rate. There is clear evidence that slowing of the embryonic heart rate (bradycardia) can cause spontaneous abortions and fetal malformations. The aim of this study was to examine the effect of four commonly used CAMs on the embryonic heart rate in vitro. A risk assessment was then generated from the results.</p><p><strong>Methods: </strong>Gestation day 13 rat embryos were exposed to the active ingredient of four herbal medicines: allicin (garlic), epigallocatechin-gallate (green tea), ginsenoside Rg3 (found in ginseng), and berberine (goldenseal). All ingredients caused embryonic bradycardia.</p><p><strong>Results and conclusion: </strong>The margin of safety was acceptable for EGCG and ginsenoside Rg3 but could not be calculated for allicin due to lack of pharmacokinetic data. The margin of safety for berberine is also likely to be acceptable under most conditions.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70016"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146111684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human-Centered Design of a Contextualized Service Delivery Model for Families of Infants With Major Congenital Anomalies in Kenya. 以人为本设计的情境化服务提供模式,为肯尼亚有重大先天性畸形的婴儿家庭。
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70014
Audrey Chepkemoi, Molly McPheron, Violet Naanyu, James G Carlucci, Caroline Kerich, Winnie Matelong, Harold Kooreman, Megan S McHenry, Caitlin Bernard, Marylydia Kiano, Roselyn Midiwo, Beverly Musick, Constantin T Yiannoutsos, Kara Wools-Kaloustian, Rena C Patel, Edwin Were, John M Humphrey

Background: Congenital anomalies (CAs) are a major cause of childhood mortality and disability in low- and middle-income countries. Our study explored caregiver experiences of infants with major CAs in Kenya and co-developed interventions using human-centered design (HCD).

Methods: We conducted a qualitative study at Kenya's second largest referral hospital (August 2023 to January 2024). Thirty-one caregivers of 23 infants with major CAs completed interviews on experiences and care needs, analyzed thematically using the socio-ecological model (individual, family, healthcare, and community domains). We conducted three HCD workshops with 19 healthcare providers and 15 caregivers to co-develop interventions to improve CA services.

Results: Caregivers reported emotional distress, stigma, and financial and geographic barriers to care. Key healthcare challenges included limited antenatal diagnosis, inadequate provider communication, insufficient peer support, and poor access to CA information. Community stigma contributed to parental isolation and distress, though social and spiritual networks offered coping support. Workshop participants identified stigma and fragmented care as critical issues and proposed feasible interventions, including caregiver support groups, dedicated counselors, provider training, integrated community counseling, improved infrastructure, and stronger support networks to enhance person-centered care.

Conclusions: Engaging caregivers and providers through HCD highlighted major psychosocial and healthcare barriers and generated contextually relevant strategies to improve care for infants with CAs in Kenya. Future research should evaluate the implementation and effects of these interventions on patient- and family-centered outcomes.

背景:先天性异常(CAs)是中低收入国家儿童死亡和残疾的主要原因。我们的研究探讨了肯尼亚主要CAs患儿的护理经验,并采用以人为本的设计(HCD)共同开发了干预措施。方法:我们在肯尼亚第二大转诊医院(2023年8月至2024年1月)进行了定性研究。23名主要ca婴儿的31名护理人员完成了关于经历和护理需求的访谈,并使用社会生态模型(个人,家庭,医疗保健和社区领域)进行了主题分析。我们与19个医疗保健提供者和15个护理人员举办了三次HCD研讨会,共同制定干预措施以改善CA服务。结果:护理人员报告了情绪困扰、耻辱、经济和地理障碍。主要的保健挑战包括产前诊断有限、提供者沟通不足、同伴支持不足以及难以获得CA信息。虽然社会和精神网络提供了应对支持,但社区耻辱助长了父母的孤立和痛苦。研讨会参与者认为耻辱和支离破碎的护理是关键问题,并提出了可行的干预措施,包括照顾者支持小组、专门的咨询师、提供者培训、综合社区咨询、改善基础设施和更强大的支持网络,以加强以人为本的护理。结论:通过HCD吸引照顾者和提供者,突出了主要的社会心理和卫生保健障碍,并产生了与环境相关的战略,以改善肯尼亚对患有CAs的婴儿的护理。未来的研究应评估这些干预措施的实施和对以患者和家庭为中心的结果的影响。
{"title":"Human-Centered Design of a Contextualized Service Delivery Model for Families of Infants With Major Congenital Anomalies in Kenya.","authors":"Audrey Chepkemoi, Molly McPheron, Violet Naanyu, James G Carlucci, Caroline Kerich, Winnie Matelong, Harold Kooreman, Megan S McHenry, Caitlin Bernard, Marylydia Kiano, Roselyn Midiwo, Beverly Musick, Constantin T Yiannoutsos, Kara Wools-Kaloustian, Rena C Patel, Edwin Were, John M Humphrey","doi":"10.1002/bdr2.70014","DOIUrl":"10.1002/bdr2.70014","url":null,"abstract":"<p><strong>Background: </strong>Congenital anomalies (CAs) are a major cause of childhood mortality and disability in low- and middle-income countries. Our study explored caregiver experiences of infants with major CAs in Kenya and co-developed interventions using human-centered design (HCD).</p><p><strong>Methods: </strong>We conducted a qualitative study at Kenya's second largest referral hospital (August 2023 to January 2024). Thirty-one caregivers of 23 infants with major CAs completed interviews on experiences and care needs, analyzed thematically using the socio-ecological model (individual, family, healthcare, and community domains). We conducted three HCD workshops with 19 healthcare providers and 15 caregivers to co-develop interventions to improve CA services.</p><p><strong>Results: </strong>Caregivers reported emotional distress, stigma, and financial and geographic barriers to care. Key healthcare challenges included limited antenatal diagnosis, inadequate provider communication, insufficient peer support, and poor access to CA information. Community stigma contributed to parental isolation and distress, though social and spiritual networks offered coping support. Workshop participants identified stigma and fragmented care as critical issues and proposed feasible interventions, including caregiver support groups, dedicated counselors, provider training, integrated community counseling, improved infrastructure, and stronger support networks to enhance person-centered care.</p><p><strong>Conclusions: </strong>Engaging caregivers and providers through HCD highlighted major psychosocial and healthcare barriers and generated contextually relevant strategies to improve care for infants with CAs in Kenya. Future research should evaluate the implementation and effects of these interventions on patient- and family-centered outcomes.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70014"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12862514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 129S1/SvImJ Mouse Strain Is Resistant to the Effects of Early Embryonic Alcohol and Other Sonic Hedgehog Inhibitors. 129S1/SvImJ小鼠品系对早期胚胎酒精和其他Sonic Hedgehog抑制剂的影响具有抗性
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70020
Ruby L Lapham, Eric W Fish, Scott E Parnell

Background: Prenatal alcohol exposure can cause fetal alcohol syndrome, but genetic variation can account for some of the observed differential susceptibility to alcohol-induced birth defects. Here we investigate an inbred mouse strain, 129S1/SvImJ (129S1), for its potential susceptibility to alcohol- and Sonic hedgehog pathway inhibitor-induced craniofacial birth defects and the ways complex genetic factors work to alter susceptibility compared to the highly alcohol-susceptible strain, the C57BL/6J (B6J).

Methods: 129S1 pregnant females were treated with alcohol (two doses of 2.9 g/kg), CP-55,940 (2.0 mg/kg), vismodegib (40 or 80 mg/kg), or smoothened agonist (12 mg/kg) during gastrulation or neurulation, then fetuses were assessed for defects. Gastrulation- and neurulation-stage embryo gene expression and apoptosis were also analyzed.

Results: 129S1 mice are completely resistant to alcohol-induced craniofacial birth defects despite high blood alcohol concentrations compared to other alcohol-susceptible mouse strains. This strain is also resistant to craniofacial birth defects after exposure to a synthetic cannabinoid, CP-55,940, and vismodegib. All three drugs inhibit the Sonic hedgehog (Shh) pathway. 129S1 embryos have higher basal expression of two key Shh-related mRNAs, Smo and Efcab7, and lower apoptosis after alcohol compared to B6J embryos. 129S1 embryos are more susceptible to birth defects after treatment with a Shh pathway agonist, smoothened agonist (SAG), than B6J embryos.

Conclusions: 129S1 embryos have higher expression of key Shh pathway genes and low apoptosis after alcohol, which may contribute to the alcohol-resistant phenotype seen in the 129S1/SvImJ strain, adding to the understanding of protective genetic factors in alcohol teratogenesis.

背景:产前酒精暴露可导致胎儿酒精综合征,但遗传变异可以解释一些观察到的对酒精引起的出生缺陷的不同易感性。在这里,我们研究了一种近交小鼠品系129S1/SvImJ (129S1)对酒精和Sonic hedgehog途径抑制剂诱导的颅面出生缺陷的潜在易感性,以及与高度酒精易感性品系C57BL/6J (B6J)相比,复杂的遗传因素如何改变易感性。方法:129S1例孕妇在原肠或神经发育期间分别给予酒精(2剂2.9 g/kg)、CP-55,940 (2.0 mg/kg)、vismodegib(40或80 mg/kg)或平滑激动剂(12 mg/kg)治疗,然后对胎儿进行缺陷评估。还分析了原肠胚期和神经胚期胚胎的基因表达和凋亡情况。结果:129S1小鼠完全抵抗酒精诱导的颅面出生缺陷,尽管血液中酒精浓度较高,但与其他酒精敏感小鼠品系相比。这种菌株在暴露于合成大麻素CP-55,940和vismodegib后也对颅面出生缺陷具有抗性。这三种药物都能抑制Sonic hedgehog (Shh)通路。与B6J胚胎相比,129S1胚胎具有更高的shh相关的两个关键mrna Smo和Efcab7的基础表达,并且酒精作用后的细胞凋亡更低。129S1胚胎在使用Shh通路激动剂(smoothened agonist, SAG)治疗后,比B6J胚胎更容易发生出生缺陷。结论:129S1胚胎在酒精作用后Shh关键通路基因表达增加,细胞凋亡减少,这可能是129S1/SvImJ菌株出现酒精抗性表型的原因,有助于了解酒精致畸的保护性遗传因素。
{"title":"The 129S1/SvImJ Mouse Strain Is Resistant to the Effects of Early Embryonic Alcohol and Other Sonic Hedgehog Inhibitors.","authors":"Ruby L Lapham, Eric W Fish, Scott E Parnell","doi":"10.1002/bdr2.70020","DOIUrl":"https://doi.org/10.1002/bdr2.70020","url":null,"abstract":"<p><strong>Background: </strong>Prenatal alcohol exposure can cause fetal alcohol syndrome, but genetic variation can account for some of the observed differential susceptibility to alcohol-induced birth defects. Here we investigate an inbred mouse strain, 129S1/SvImJ (129S1), for its potential susceptibility to alcohol- and Sonic hedgehog pathway inhibitor-induced craniofacial birth defects and the ways complex genetic factors work to alter susceptibility compared to the highly alcohol-susceptible strain, the C57BL/6J (B6J).</p><p><strong>Methods: </strong>129S1 pregnant females were treated with alcohol (two doses of 2.9 g/kg), CP-55,940 (2.0 mg/kg), vismodegib (40 or 80 mg/kg), or smoothened agonist (12 mg/kg) during gastrulation or neurulation, then fetuses were assessed for defects. Gastrulation- and neurulation-stage embryo gene expression and apoptosis were also analyzed.</p><p><strong>Results: </strong>129S1 mice are completely resistant to alcohol-induced craniofacial birth defects despite high blood alcohol concentrations compared to other alcohol-susceptible mouse strains. This strain is also resistant to craniofacial birth defects after exposure to a synthetic cannabinoid, CP-55,940, and vismodegib. All three drugs inhibit the Sonic hedgehog (Shh) pathway. 129S1 embryos have higher basal expression of two key Shh-related mRNAs, Smo and Efcab7, and lower apoptosis after alcohol compared to B6J embryos. 129S1 embryos are more susceptible to birth defects after treatment with a Shh pathway agonist, smoothened agonist (SAG), than B6J embryos.</p><p><strong>Conclusions: </strong>129S1 embryos have higher expression of key Shh pathway genes and low apoptosis after alcohol, which may contribute to the alcohol-resistant phenotype seen in the 129S1/SvImJ strain, adding to the understanding of protective genetic factors in alcohol teratogenesis.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70020"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Children With Biliary Atresia Have Substantial Morbidity in Early Childhood and a High Risk of Liver Transplantation. 胆道闭锁儿童早期发病率高,肝移植风险高。
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70024
Mads Damkjær, Joachim Tan, Maria Loane, Joanne Given, Elisa Ballardini, Clara Cavero-Carbonell, Mika Gissler, Sue Jordan, Anna Pierini, Anke Rissmann, David Tucker, Ester Garne, Joan K Morris

Background: Biliary atresia is a rare but severe congenital anomaly associated with substantial morbidity and mortality in early childhood. Population-based estimates of survival, surgical management, and liver transplantation across Europe remain limited. This study aimed to describe mortality and morbidity among children born with biliary atresia using multinational population-based data.

Methods: We investigated children diagnosed with biliary atresia across nine registries from five countries within the European surveillance of congenital anomalies network (EUROCAT), covering births from 1995 to 2014. The data were linked to hospital databases and adjusted for regional differences and follow-up length.

Results: Our cohort included 171 children, with an infant mortality rate of 12.3% (95% CI: 7.8-17.6) and a mortality rate before age five of 18.5% (95% CI: 10.7-27.7). Among these children, 151 had undergone surgery, including 133 who received the Kasai procedure by the age of 1 year at a median age of 57 days (95% CI: 51-62 days). By age five, 37% (adjusted percentage, 95% CI: 30-44) had undergone liver transplantation, with the median age at transplantation being 318 days (95% CI: 244-391 days). Median age at death in the first year was over 6 months and was not immediately after surgery.

Conclusion: The high mortality and the substantial need for liver transplantation within the first year of life underline the severity of biliary atresia. This highlights the urgent need for further research into pregnancy exposures that may contribute to this rare but severe congenital anomaly to develop primary prevention strategies.

背景:胆道闭锁是一种罕见但严重的先天性异常,在儿童早期具有很高的发病率和死亡率。在欧洲,基于人群的生存率、手术治疗和肝移植的估计仍然有限。本研究旨在利用跨国人群数据描述先天性胆道闭锁儿童的死亡率和发病率。方法:我们调查了欧洲先天性异常监测网络(EUROCAT)中来自5个国家的9个登记处诊断为胆道闭锁的儿童,涵盖1995年至2014年的出生。这些数据与医院数据库相关联,并根据地区差异和随访时间进行了调整。结果:我们的队列包括171名儿童,婴儿死亡率为12.3% (95% CI: 7.8-17.6), 5岁前死亡率为18.5% (95% CI: 10.7-27.7)。在这些儿童中,151人接受了手术,其中133人在1岁时接受了Kasai手术,中位年龄为57天(95% CI: 51-62天)。到5岁时,37%(调整百分比,95% CI: 30-44)接受了肝移植,移植时的中位年龄为318天(95% CI: 244-391天)。第一年死亡的中位年龄超过6个月,并不是在手术后立即死亡。结论:高死亡率和出生后一年内肝移植的大量需求强调了胆道闭锁的严重性。这突出了迫切需要进一步研究妊娠暴露可能导致这种罕见但严重的先天性异常,以制定一级预防策略。
{"title":"Children With Biliary Atresia Have Substantial Morbidity in Early Childhood and a High Risk of Liver Transplantation.","authors":"Mads Damkjær, Joachim Tan, Maria Loane, Joanne Given, Elisa Ballardini, Clara Cavero-Carbonell, Mika Gissler, Sue Jordan, Anna Pierini, Anke Rissmann, David Tucker, Ester Garne, Joan K Morris","doi":"10.1002/bdr2.70024","DOIUrl":"https://doi.org/10.1002/bdr2.70024","url":null,"abstract":"<p><strong>Background: </strong>Biliary atresia is a rare but severe congenital anomaly associated with substantial morbidity and mortality in early childhood. Population-based estimates of survival, surgical management, and liver transplantation across Europe remain limited. This study aimed to describe mortality and morbidity among children born with biliary atresia using multinational population-based data.</p><p><strong>Methods: </strong>We investigated children diagnosed with biliary atresia across nine registries from five countries within the European surveillance of congenital anomalies network (EUROCAT), covering births from 1995 to 2014. The data were linked to hospital databases and adjusted for regional differences and follow-up length.</p><p><strong>Results: </strong>Our cohort included 171 children, with an infant mortality rate of 12.3% (95% CI: 7.8-17.6) and a mortality rate before age five of 18.5% (95% CI: 10.7-27.7). Among these children, 151 had undergone surgery, including 133 who received the Kasai procedure by the age of 1 year at a median age of 57 days (95% CI: 51-62 days). By age five, 37% (adjusted percentage, 95% CI: 30-44) had undergone liver transplantation, with the median age at transplantation being 318 days (95% CI: 244-391 days). Median age at death in the first year was over 6 months and was not immediately after surgery.</p><p><strong>Conclusion: </strong>The high mortality and the substantial need for liver transplantation within the first year of life underline the severity of biliary atresia. This highlights the urgent need for further research into pregnancy exposures that may contribute to this rare but severe congenital anomaly to develop primary prevention strategies.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70024"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Teratogenic Concerns in the Coronavirus Disease of 2019 Era. 2019年冠状病毒病致畸问题调查
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70010
Kate Richardson, Emily C Daykin, Kathleen Shields, S Shahrukh Hashmi, Lorrie Harris-Sagaribay, Molly Daniels, Myla Ashfaq

Background: MotherToBaby (MTB) is a teratogen information service that provides information about exposures during pregnancy and breastfeeding to the public and healthcare providers. During the Coronavirus Disease of 2019 (COVID-19) pandemic, MTB received an influx of queries regarding the teratogenicity of the virus and the vaccine. The purpose of this study was to assess the frequency and type of exposures asked about prior to the onset of the COVID-19 pandemic through March 2022 and to evaluate the demographics of individuals who made inquiries.

Methods: Data from MTB contacts (2018-2022) were accessed through a data-sharing agreement. The data were cleaned and standardized by coding all exposures into 11 established categories before linking demographic and exposure files into a single dataset. Analyses included descriptive statistics, chi-square tests, and logistic regression conducted in Excel and STATA 17.0, with statistical significance set at a 0.01% error rate.

Results: The total number of contacts increased from 2019 to 2022, and the exposure category with the highest number of contacts was prescription medications, followed by COVID-19-related exposures. Peaks in the number of contacts relating to COVID-19 correlate with various pandemic milestones, such as when vaccines were approved by the U.S. Food and Drug Administration (FDA).

Conclusion: These data provide valuable information for healthcare providers and agencies, such as the Centers for Disease Control and Prevention (CDC), to better prepare for future pandemics and epidemics.

背景:母亲对婴儿(MTB)是一项致畸原信息服务,向公众和卫生保健提供者提供有关妊娠和哺乳期间暴露的信息。在2019年冠状病毒病(COVID-19)大流行期间,MTB收到了大量关于该病毒和疫苗致畸性的询问。本研究的目的是评估在2019冠状病毒病大流行爆发至2022年3月之前询问的暴露频率和类型,并评估询问者的人口统计数据。方法:通过数据共享协议访问2018-2022年MTB接触者的数据。在将人口统计和暴露文件链接到单个数据集之前,通过将所有暴露编码为11个既定类别来清理和标准化数据。分析采用描述性统计、卡方检验和logistic回归,分别在Excel和STATA 17.0中进行,统计学显著性设置为错误率为0.01%。结果:2019 - 2022年接触者总数呈上升趋势,接触者数量最多的接触类别为处方药,其次是与covid -19相关的接触。与COVID-19相关的接触人数高峰与各种大流行里程碑相关,例如疫苗获得美国食品和药物管理局(FDA)批准的时间。结论:这些数据为医疗保健提供者和机构(如疾病控制和预防中心(CDC))提供了有价值的信息,以便更好地为未来的流行病和流行病做好准备。
{"title":"Investigation of Teratogenic Concerns in the Coronavirus Disease of 2019 Era.","authors":"Kate Richardson, Emily C Daykin, Kathleen Shields, S Shahrukh Hashmi, Lorrie Harris-Sagaribay, Molly Daniels, Myla Ashfaq","doi":"10.1002/bdr2.70010","DOIUrl":"10.1002/bdr2.70010","url":null,"abstract":"<p><strong>Background: </strong>MotherToBaby (MTB) is a teratogen information service that provides information about exposures during pregnancy and breastfeeding to the public and healthcare providers. During the Coronavirus Disease of 2019 (COVID-19) pandemic, MTB received an influx of queries regarding the teratogenicity of the virus and the vaccine. The purpose of this study was to assess the frequency and type of exposures asked about prior to the onset of the COVID-19 pandemic through March 2022 and to evaluate the demographics of individuals who made inquiries.</p><p><strong>Methods: </strong>Data from MTB contacts (2018-2022) were accessed through a data-sharing agreement. The data were cleaned and standardized by coding all exposures into 11 established categories before linking demographic and exposure files into a single dataset. Analyses included descriptive statistics, chi-square tests, and logistic regression conducted in Excel and STATA 17.0, with statistical significance set at a 0.01% error rate.</p><p><strong>Results: </strong>The total number of contacts increased from 2019 to 2022, and the exposure category with the highest number of contacts was prescription medications, followed by COVID-19-related exposures. Peaks in the number of contacts relating to COVID-19 correlate with various pandemic milestones, such as when vaccines were approved by the U.S. Food and Drug Administration (FDA).</p><p><strong>Conclusion: </strong>These data provide valuable information for healthcare providers and agencies, such as the Centers for Disease Control and Prevention (CDC), to better prepare for future pandemics and epidemics.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70010"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146104061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
County-Level Environmental Quality and Risk of Hypospadias in Arkansas. 阿肯色州尿道下裂的县级环境质量与风险。
IF 1.6 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2026-02-01 DOI: 10.1002/bdr2.70022
Lydia Famuyide, Jenil Patel, Wendy N Nembhard

Background: Hypospadias is one of the most common genital defects in boys, affecting about 1 in 125 live-born boys. Several studies have examined the association between a single environmental exposure and risk of hypospadias, but few have examined the possible effects of multiple environmental exposures simultaneously. Thus, we aimed to address this gap by examining the association between cumulative maternal prenatal environmental exposures and hypospadias occurrence in offspring.

Methods: We conducted a retrospective cohort study using data from 2006 to 2010 Arkansas environmental quality index (EQI), its domains (air, water, land, sociodemographic, and built) and related county-level estimates, matched to data on infants diagnosed with hypospadias and identified from the Arkansas Reproductive Health Monitoring System born 2005-2012. We classified the EQI and its domains into quartiles. Crude and adjusted prevalence ratios (PR) and 95% CI were estimated with Poisson regression analyses with cluster-robust standard error to estimate the association between EQI and the prevalence of hypospadias.

Results: There was no statistically significant association between boys born in areas with fair environmental quality compared to those born in areas with better environmental quality (adjusted PR = 1.01; 95% CI = 0.86, 1.18). For the air domain, we observed a higher prevalence of hypospadias among boys born to women living in areas with fair air quality compared to those living in areas with excellent air quality (adjusted PR = 1.18; 95% CI = 1.01, 1.39).

Conclusion: Our results suggest that there was no significant association between overall poor environmental quality index and the prevalence of hypospadias. However, poorer air quality was associated with a higher prevalence of hypospadias among offspring.

背景:尿道下裂是男孩最常见的生殖器缺陷之一,每125个活产男孩中就有1个患有尿道下裂。一些研究已经检查了单一环境暴露与尿道下裂风险之间的关系,但很少有研究同时检查多种环境暴露的可能影响。因此,我们的目的是通过检查累积母体产前环境暴露与后代尿道下裂发生之间的关系来解决这一差距。方法:我们使用2006年至2010年阿肯色州环境质量指数(EQI)及其领域(空气、水、土地、社会人口和建筑)和相关县级估计数据进行了回顾性队列研究,并与2005-2012年出生的阿肯色州生殖健康监测系统中诊断为尿道下裂的婴儿数据相匹配。我们将EQI及其域划分为四分位数。用泊松回归分析估计粗患病率和校正患病率(PR)和95% CI,具有聚类稳健性标准误差,以估计EQI与尿道下裂患病率之间的关系。结果:出生在环境质量较好的地区的男孩与出生在环境质量较好的地区的男孩之间无统计学意义的关联(校正PR = 1.01; 95% CI = 0.86, 1.18)。对于空气领域,我们观察到生活在空气质量良好地区的女性所生男孩的尿道下裂患病率高于生活在空气质量良好地区的女性(调整后的PR = 1.18; 95% CI = 1.01, 1.39)。结论:我们的研究结果表明,总体差的环境质量指数与尿道下裂的患病率没有显著的相关性。然而,较差的空气质量与后代中尿道下裂的较高患病率有关。
{"title":"County-Level Environmental Quality and Risk of Hypospadias in Arkansas.","authors":"Lydia Famuyide, Jenil Patel, Wendy N Nembhard","doi":"10.1002/bdr2.70022","DOIUrl":"https://doi.org/10.1002/bdr2.70022","url":null,"abstract":"<p><strong>Background: </strong>Hypospadias is one of the most common genital defects in boys, affecting about 1 in 125 live-born boys. Several studies have examined the association between a single environmental exposure and risk of hypospadias, but few have examined the possible effects of multiple environmental exposures simultaneously. Thus, we aimed to address this gap by examining the association between cumulative maternal prenatal environmental exposures and hypospadias occurrence in offspring.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study using data from 2006 to 2010 Arkansas environmental quality index (EQI), its domains (air, water, land, sociodemographic, and built) and related county-level estimates, matched to data on infants diagnosed with hypospadias and identified from the Arkansas Reproductive Health Monitoring System born 2005-2012. We classified the EQI and its domains into quartiles. Crude and adjusted prevalence ratios (PR) and 95% CI were estimated with Poisson regression analyses with cluster-robust standard error to estimate the association between EQI and the prevalence of hypospadias.</p><p><strong>Results: </strong>There was no statistically significant association between boys born in areas with fair environmental quality compared to those born in areas with better environmental quality (adjusted PR = 1.01; 95% CI = 0.86, 1.18). For the air domain, we observed a higher prevalence of hypospadias among boys born to women living in areas with fair air quality compared to those living in areas with excellent air quality (adjusted PR = 1.18; 95% CI = 1.01, 1.39).</p><p><strong>Conclusion: </strong>Our results suggest that there was no significant association between overall poor environmental quality index and the prevalence of hypospadias. However, poorer air quality was associated with a higher prevalence of hypospadias among offspring.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"118 2","pages":"e70022"},"PeriodicalIF":1.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Birth Defects Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1